While PPAR-γ has been widely studied for its antiangiogenic properties[25], recent studies now indicate that PPAR-α may have antiangiogenic properties as well [26, 27],a finding with potential therapeutic implications for wet AMD. This evidence concerns the gene PPARA and wet macular degeneration.